Know about Tissue Heart Valves
Tissue or biological heart valve is made from animal tissue, such as porcine (pig) or bovine (cow), as it is similar to human tissue. Tissue heart valves need chemical treatment for protection and stent or frame for support. Tissue heart valves can last up to 10 to 20 years. Patients implanted with these devices do not require anticoagulation medication for a long time. Major advantages of tissue heart valves involve easy tolerance by the body and an average life expectancy of more than 15 years. However, their drawback is their durability only up to 10 to 20 years, thereby creating the need for a second replacement surgery.
The tissue heart valves market is anticipated to grow substantially due to high prevalence of heart valve diseases, which is constantly rising due to socioeconomic factors, such as lifestyle-induced dietary, physical inactivity. Moreover, increase in demand for minimally invasive procedures and technological advancements is expected to boost the growth of the market in the forecast period.
The tissue heart valves market is segmented on the basis of type and application. Based on type the market is segmented as natural material and synthetic material. On the basis of application, the market is categorized as heart surgery and cardiovascular disease.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the tissue heart valves market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The tissue heart valves market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Comments
Post a Comment